NCI's Gong Xingfeng Reports Strong Start in Dividend Insurance Transition, 2026 Focus on Expanding Product Portfolio

Deep News
03/30

On March 30, NCI held its 2025 annual results presentation. President and Chief Financial Officer Gong Xingfeng stated that the company firmly advanced its dividend insurance transition in 2025, successfully achieving a favorable start, primarily reflected in breakthroughs at the sales level.

Gong Xingfeng emphasized that 2025 marks only the beginning of the dividend insurance transition. In 2026, the company will continue to deepen this transformation, with a key focus on broadening product types, increasing sales efforts for risk annuities, and strengthening product innovation. The company plans to capitalize on the policy benefits for dividend health insurance, enhance product suitability management, adhere to selling appropriate products to suitable customers, and resolutely avoid sales misconduct.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10